The Magazine for Sleep Professionals
Saturday, April 4, 2026
ProSomnus Sleep Technologies announces EVO Guided. EVO Guided is a new precision, custom oral device for the treatment of Obstructive Sleep Apnea (“OSA”). FDA cleared, patented and covered by most medical insurances, EVO Guided is the first oral device bioengineered to dilate the oropharynx and the velopharynx for optimal therapeutic […]
Neuroscientists have found the average person processes roughly 74 gigabytes of information every day.1 That is the equivalent of watching 16 movies, reading more than 200,000 words, or scrolling on TikTok for approximately 200 hours. In other words, we are inundated with information from every angle — social media, websites, […]
Panthera Dental is proud to announce that their abstracts were accepted for poster presentation at the AADSM and for poster and oral presentation at the SLEEP Annual Meetings. The oral presentation is part of a session entitled “Contemporary Management of Sleep Apnea” (O-13). Information regarding the 2025 IIR Grant will […]
Panthera Dental, a global leader in CAD/CAM implant solutions and dental sleep medical devices, proudly announces the launch of its best-in-class BioMatch System, set to streamline the field of oral appliance therapy (OAT). The BioMatch System is designed to make ordering of a patient-matched appliance an effortless process, ease dental […]
Treating obstructive sleep apnea (OSA) is at an exciting crossroads where therapeutic advances are coming of age in the era of precision medicine. In the past, the only option was continuous positive airway pressure (CPAP) therapy. Now, there are many effective alternatives to manage sleep apnea and even more on […]
P4 medicine is an evolving approach to personalized medicine that involves four key elements of care: 1) predicting who will develop disease and comorbidities, 2) preventing rather than reacting to disease, 3) personalizing diagnosis and treatment, 4) having patients participate in their own care.1 This approach is gaining traction in […]
The Slow Wave DS8™ oral appliance therapy (OAT), initially FDA-cleared for the prescription treatment of obstructive sleep apnea (OSA) in 2021 (K191320), has now been dually cleared by the FDA for the treatment of sleep bruxism (K240463). This makes the Slow Wave DS8, now marketed as BROSA™ when sold as […]
There has been an increasing number of studies looking at orofacial myofunctional therapy (OMT) as a promising adjunctive treatment for obstructive sleep apnea (OSA).1 OMT essentially helps the patient to retrain the muscles around the face, mouth, and tongue to establish correct oral rest posture and functioning of the oral […]
ProSomnus Sleep Technologies announced record revenues for the quarter that ended June 30, 2024, as it formally emerged from reorganization on August 5, 2024. Revenues for the second quarter totaled a record $9.1 million reflecting increasing orders for the Company’s precision intraoral medical devices. These quarterly results reflect a 22% […]
